Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial

  • Publikationsjahr: 2021
  • Titel: Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial
  • Autoren: Meiser, A.;Volk, T.;Wallenborn, J.;Guenther, U.;Becher, T.;Bracht, H.;Schwarzkopf, K.;Knafelj, R.;Faltlhauser, A.;Thal, S. C.;Soukup, J.;Kellner, P.;Drüner, M.;Vogelsang, H.;Bellgardt, M.;Sackey, P.
  • Journal: Lancet Respir Med
  • DOI: 10.1016/s2213-2600(21)00323-4